IPGP

Third-quarter revenue increased 15% year over year to $288 million. Semiconductor laser revenue more than doubled year over year.

IPG Photonics Corporation (IPGP) Q3 2026 Earnings Call Transcript

IPG Photonics NASDAQ: IPGP reported third-quarter revenue growth of 15% year over year to $288 million, marking its fourth consecutive quarter of double-digit growth as industrial and advanced solutions both contributed to the increase.

IPG Photonics (IPGP) came out with quarterly earnings of $0.61 per share, beating the Zacks Consensus Estimate of $0.49 per share. This compares to earnings of $0.35 per share a year ago.

Double-Digit Revenue Growth Driven by Strategic Initiatives Across Industrial and Advanced Solutions Focused on Driving Margin Expansion MARLBOROUGH, Mass., Nov. 03, 2026 (GLOBE NEWSWIRE) -- IPG Photonics Corporation (NASDAQ: IPGP) today reported financial results for the third quarter ended September 30, 2026.

U.S. Fund A Shares (without sales charge) posted a return of 4.36% in third-quarter 2026. The US Fund outperformed the S&P 500 Index in the period. Shares of Meta performed well following the strong reception of Muse, its personalized AI assistance app.

MARLBOROUGH, Mass., Oct. 20, 2026 (GLOBE NEWSWIRE) -- IPG Photonics Corporation (Nasdaq: IPGP) will release its third quarter 2026 financial results before the market opens on Tuesday, November 3, 2026. The Company will hold a conference call to review these results at 10:00 a.m. ET on the same day. To access the call, please dial 877-407-6184 in the United States or 201-389-0877 internationally. A live webcast of the call will also be available and archived in the investor relations section of the Company's website at investor.ipgphotonics.com.

MARLBOROUGH, Mass., Oct. 05, 2026 (GLOBE NEWSWIRE) -- IPG Photonics today announced that from October 6th though October 8th, 2026, IPG Defense will participate in Land Forces 2026 in Perth, Australia to showcase CROSSBOW™ High-Energy Laser (HEL) Systems. This key industry event provides a platform to forge strategic alliances and collaborate to shape the future of the global aerospace and defense market.

The latest rebalance of VettaFi's Thematic Rotation Quality Momentum Screened Index (TQRMS), tracked by the NBI Thematic Rotation ETF (NTHM:TSX), reshapes the portfolio around a new set of themes. GLP-1 weight loss drug manufacturers and midstream energy join the index, while battery technology & storage and software-as-a-service (SaaS) exit.

I initiate coverage on IPG Photonics with a 'Buy' rating, citing a compelling business mix transition. IPGP's acquisition of Lumibird Medical boosts exposure to the medical end -market, boasting a superior financial profile than its legacy operations. The company is shifting organically toward promising business areas like AI, defense, and medical.